TNF Signaling in Alzheimer's Disease Neuropathology

About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005281
Summary
Levels of TNF, a potent pro-inflammatory cytokine that has both neurotoxic and neuroprotective effects, are low in normal adult brains. However, TNF levels have been found to be significantly elevated in the brain fluid of patients with Mild Cognitive Impairment (MCI) who progress to develop AD. Therefore, the overall aim of Dr. Tansey’s studies is to identify the cellular and molecular mechanisms by which TNF participates in AD pathology. Completion of these studies should provide new and critical information about the role of TNF in AD progression. Results may also help determine if currently available anti-TNF therapies might be feasibly modified, or new ones developed, for treating AD patients during specific therapeutic windows to slow progression of this devastating disease.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD